5-HT4R modulators: a patent landscape

Pharm Pat Anal. 2021 Jul;10(4):179-181. doi: 10.4155/ppa-2021-0017. Epub 2021 Aug 9.

Authors

Patrick Dallemagne¹, Christophe Rochais¹

Affiliation

¹ Normandie University, UNICAEN, CERMN, Caen, 14000, France.

PMID: 34365797
DOI: 10.4155/ppa-2021-0017

No abstract available

Keywords: 5-HT4R; depression; gastrointestinal diseases; neurodegenerative diseases; stress.

Publication types

Editorial